Experimental study demonstrates high-efficiency enantioselective separation in racemic drugs using chiral mesoporous silica nanochannels, suggesting a robust platform for chiral purification.
The separation of racemic compounds by chiral nanochannels has attracted extensive attention. However, the fabrication of high-performance chiral nanochannels is still a challenge owing to the difficulty in magnifying the weak chiral interaction to macroscopic properties of materials. Herein, by introducing a l-alanine-pillar[5]arene host to achiral ordered mesoporous silica (OMS), chiral OMS nanochannels were fabricated, which exhibited excellent selectivity (ee value up to 90.2%) to separate racemic drugs with promising reusability and stability. Besides, it was identified that enantioselective separation took place through a molecular-recognition-adsorbed transport mechanism. This work highlights the great potential of chiral OMS nanochannels as a platform for enantioselective separation.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: